JCI
36
4
VIX
15
-3
PNW
64
-2
FOXA
32
-10
SO
57
13
STT
33
5
EQR
36
-6
CI
46
-12
ZION
55
5
CMI
63
5
DNB
37
-4
PG
53
2
DO
48
4
HP
71
6
EXR
19
-11
BBY
41
-3
CMS
51
-2
AIZ
66
2
PGR
67
3
CMCSA
32
-6
JCI
36
4
VIX
15
-3
PNW
64
-2
FOXA
32
-10
SO
57
13
STT
33
5
EQR
36
-6
CI
46
-12
ZION
55
5
CMI
63
5
DNB
37
-4
PG
53
2
DO
48
4
HP
71
6
EXR
19
-11
BBY
41
-3
CMS
51
-2
AIZ
66
2
PGR
67
3
CMCSA
32
-6
Financhill
Back

Reata Pharmaceuticals Quote, Financials, Valuation and Earnings

Big Gains Still to Be Had in 2023

Grab a FREE ticket right now on this page!
Buy
66

RETA
Reata Pharmaceuticals

Last Price:
169.28
Seasonality Move:
38.26%

7 Day Trial

ALL ACCESS PASS

$ 7

Is Elon Musk right about AI?

Learn all about it here.

Reata Pharmaceuticals Price Quote

$169.28
+0.02 (+0.17%)
(Updated: September 2, 2023 at 6:20 AM ET)

Reata Pharmaceuticals Key Stats

Buy
66
Reata Pharmaceuticals (RETA) is a Buy
Day range:
$168.90 - $169.50
52-week range:
$21.83 - $169.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
73.97%
Volume:
366K
Avg. volume:
1.3M
1-year change:
564.03%
Market cap:
$6.5B
Revenue:
$2.2M
EPS:
$-2.98

How Much Does Reata Pharmaceuticals Make?

Data Unavailable

Is Reata Pharmaceuticals Growing As A Company?

  • What Is Reata Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 28.85%
  • What Is Reata Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Reata Pharmaceuticals Stock Price Performance

What Is Reata Pharmaceuticals 52-Week High & Low?

Reata Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Reata Pharmaceuticals?

Is Reata Pharmaceuticals Cash Flow Positive?

  • What Is RETA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$248.3M
  • What Is Reata Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $90.6M
  • What Is Reata Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $59.4M

Reata Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    RETA return on invested capital is -1177.57%
  • What Is Reata Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -16.31%
  • What Is RETA Return On Equity?
    ROE is a measure of profitability and is 0%

Reata Pharmaceuticals Earnings Date & Stock Price

Reata Pharmaceuticals Competitors

Reata Pharmaceuticals Dividend Yield

Data Unavailable

Reata Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.44%
Revenue: 2885.04% -100%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 10
Sell Recommendations: 0
Price Target: 172.45
Upside from Last Price: 1.88%

Major Shareholders

  • How many RETA shares are owned by institutional investors?
    49.1M RETA shares are owned by institutional investors
  • How many RETA shares are owned by insiders?
    600.1K RETA shares are owned by insiders